Discontinue anticoagulant therapy (Negative d-dimer)
OtherPatients with negative d-dimer discontinue long-term anticoagulant therapy.
NCT Number: NCT00720915
The purpose of this study is to determine if the risk of recurrent venous thromboembolism (VTE) after stopping therapy is low and acceptable in patients with a first unprovoked proximal deep vein thrombosis (DVT) or pulmonary embolism (PE) who have completed 3 months of therapy and who have a negative D-dimer test on therapy and 1 month after stopping therapy.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Hamilton General Hospital, Hamilton, Ontario, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients with negative d-dimer discontinue long-term anticoagulant therapy.
Patients with positive d-dimer continue or re-start on anticoagulant therapy
Time frame: up to 7 years
Time frame: up to 7 years
Time frame: up to 7 years
Time frame: up to 7 years
McMaster University
Other
A Cohort Study to Test That There is a Low Risk of Recurrent VTE in Patients With a First Episode of Unprovoked VTE Who Stop Anticoagulant Therapy After 3 Months of Treatment in Response to Negative D-dimer Testing
Acronym: DODS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07689136
Cardiovascular Diseases, Deep Vein Thrombosis
Tunis, Tunisia
View Trial DetailsNCT03682419
Antiphospholipid Syndrome, Arrhythmias, Cardiac
Glasgow, United Kingdom
View Trial DetailsNCT04737954
Cardiovascular Diseases, Deep Vein Thrombosis
Hamburg, Germany
View Trial DetailsNCT04168203
Cardiovascular Diseases, Deep Vein Thrombosis
Boston, Massachusetts, United States
View Trial Details